@Article{,
AUTHOR = {Emilie Dardenne, Quentin Manach, Pietro Grande, Riccardo Campi, Florie Gomez, Benjamin Granger, Vincent Misrai, Marc-Olivier Bitker, Pierre Mozer, Morgan Roupret},
TITLE = {Satisfaction and surgical outcomes in patients undergoing penile prosthesis implantation for drug-refractory erectile dysfunction: mid-term results in a single center French cohort},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {26},
YEAR = {2019},
NUMBER = {6},
PAGES = {10039--10044},
URL = {http://www.techscience.com/CJU/v26n6/60438},
ISSN = {1488-5581},
ABSTRACT = {<b>Introduction:</b> To investigate the mid-term results of penile prosthesis (PP) implantation in patients with erectile dysfunction (ED) from a “real-life” historic cohort in a French academic center.<br/>
<b>Materials and methods:</b> All patients receiving an inflatable PP between 2004 and 2014 in our institution were included in this study. ED was assessed preoperatively using the IIEF-5 questionnaire. Postoperative satisfaction with the PP was assessed using the EDITS questionnaire at each follow-up visit. Postoperative complications were classed according to the Clavien classification. Surgical and functional outcomes were recorded prospectively.<br/>
<b>Results:</b> Seventy-six men received a PP during the 10-year study period. Median (IQR) age was 62 (58-69) years. The main causes of ED were radical prostatectomy (n = 40; 53%) and diabetes mellitus (n = 28; 36.8%). Five patients (6.6%) had a non-functioning PP in place requiring complete substitution or a previous penile implant which had already been removed at the time of surgery. Sixty-nine (90.8%) patients received an AMS 700 CX device and seven (9.2%) a Coloplast Titan. The surgical approach was penoscrotal in 45 (59.2%) and infrapubic in 31 (40.8%). Intraoperative complications occurred in four (5%) patients, without compromising the intervention. Postoperative complications occurred in 27 (35.5%) patients: 17 (22%) were Clavien I-II and 10 (13%) Clavien III. All major complications resulted in prosthesis removal (n = 9; 11.8%) or revision (n = 1; 1.3%). Median (IQR) follow-up was 43 (34-55) months. At the end of follow-up, 70 (92.1%) patients had a functional implant. Fifty-four (71.1%) patients were satisfied with the device at the 6-month follow-up visit and beyond. Early satisfaction (at 3 months) was reported by 44 (57.9%) patients. A previous PP was the only significant risk factor for prosthesis removal (p = 0.001).<br/>
<b>Conclusion:</b> PP implantation is a safe and satisfactory treatment for ED. However, patient selection remains crucial in determining the post-surgical success of this procedure.},
DOI = {}
}